Advertisement

Treatment of hidradenitis suppurativa: Surgery and yeast (Saccharomyces cerevisiae)–exclusion diet. Results after 6 years

Published:February 22, 2020DOI:https://doi.org/10.1016/j.surg.2019.12.015

      Abstract

      Background

      Hidradenitis suppurativa is a complex disorder, the pathogenesis of which is still unsolved. The known association between hidradenitis suppurativa and Crohn’s disease, an autoimmune disease diagnosed with the presence of Anti-Saccharomyces cerevisiae antibodies of the IgG family, suggests that a much more complex mechanism than a simple infectious disorder is involved. The goal of this study is to report patients’ characteristics and the outcome of 6 years of a yeast (Saccharomyces cerevisiae)-exclusion diet and surgery in the treatment of hidradenitis suppurativa.

      Method

      We analyzed 185 patients with hidradenitis suppurativa with a self-evaluative questionnaire. Thirty-seven patients were treated in our center following our protocol. The other 148 were members of a support group for patients with hidradenitis suppurativa treated by other centers.

      Results

      In 80% of patients who had the onset of hidradenitis suppurativa before the age of 30, the female to male ratio was 3.34:1, 74% were active smokers, and 5% also had Crohn’s disease. In the diet group, 70% had an improvement of hidradenitis suppurativa symptomatology, 81% of whom in less than 6 months. Also, 87% of patients demonstrated an immediate recurrence of skin lesions less than a week after consuming a food containing the yeast. Immunologic testing showed intolerance to yeast, wheat, and cow’s milk in 20%, 29%, and 23% of patients, respectively.

      Conclusion

      The analysis confirmed the stabilization and regression of hidradenitis suppurativa with our diet, presumably by decreasing the local and systemic inflammation, leading to a less invasive operative treatment. These new findings seem to link hidradenitis suppurativa to food intolerance and gut dysbiosis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gill L.
        • Williams M.
        • Hamzavi I.
        Update on hidradenitis suppurativa: connecting the tracts.
        F1000Prime Rep. 2014; 6: 112
        • Naldi L.
        Epidemioloy.
        in: Jemec G.B.E. Revuz J. Leyden J.J. Hidradenitis Suppurativa. Springer, Berlin2006
        • Revuz J.E.
        • Canoui-Poitrine F.
        • Wolkenstein P.
        • et al.
        Prevalence and factors associated with hidradenitis suppurativa: results from two case.
        J Am Acad Dermatol. 2008; 59: 596-601
        • Jemec G.B.
        The symptomatology of hidradenitis suppurativa in women.
        Br J Dermatol. 1988; 119: 345-350
        • Jemec G.B.
        • Heidenheim M.
        • Nielsen N.H.
        The prevalence of hidradenitis suppurativa and its potential precursor lesions.
        J Am Acad Dermatol. 1996; 35: 191-194
        • Lee D.E.
        • Clark A.K.
        • Shi V.Y.
        Hidradenitis suppurativa: Disease burden and etiology in skin of color.
        Dermatology. 2017; 233: 456-461
        • Naik H.B.
        • Paul M.
        • Cohen S.R.
        • Alavi A.
        • Suàrez-Fariñas M.
        • Lowes M.A.
        Distribution of self-reported hidradenitis suppurativa age at onset.
        JAMA Dermatology. 2019; (Available from:)
        • Vekic D.A.
        • Frew J.W.
        • Woods J.
        • Cains G.D.
        Adopting the orphan: the importance of recognizing hidradenitis suppurative as a systemic auto inflammatory disease.
        Australas J. Dermatol. 2016; 57: 69-70
        • Margesson L.J.
        • Danby F.W.
        Hidradenitis suppurativa.
        Best Pract Res Clin Obstet Gynaecol. 2014; 28: 1013-1027
        • Thorlacius L.
        • Cohen A.D.
        • Gislason G.H.
        • Jemec G.B.E.
        • Egeberg A.
        Increased suicide risk in patients with hidradenitis suppurativa.
        J Invest Dermatol. 2018; 138: 52-57
        • Anstey A.V.
        • Wilkinson J.D.
        • Lord P.
        Squamous cell carcinoma complicating hidradenitis suppurativa.
        Br J Dermatol. 1990; 123: 527-531
        • Losanoff J.E.
        • Sochaki P.
        • Khoury N.
        • Levi E.
        • Salwen W.A.
        • Masson M.D.
        Squamous cell carcinoma complicating chronic suppurative hydradenitis.
        Am Surg. 2011; 77: 1449-1453
        • Garg A.
        • Hundal J.
        • Strunk A.
        Overall and subgroup prevalence of Crohn disease among patients with hidradenitis suppurativa: A population-based analysis in the United States.
        JAMA Dermatol. 2018; 154: 814-818
        • Kirthi S.
        • Hellen R.
        • O'Connor R.
        • Connolly M.
        • Tobin A.M.
        • McNamara D.
        Hidradenitis suppurativa and Crohn's disease: A case series.
        Ir Med J. 2017; 110: 618
        • Cohen L.
        • Fathallah N.
        • Pommaret E.
        • de Parades V.
        • Cosnes J.
        L’association maladie de Crohn et maladie de Verneuil : une crise annoncée ?.
        Presse Med. 2017; : 777-778
        • Salgado-Boquete L.
        • Romaní J.
        • Carrión L.
        • Marín-Jiménez I.
        Epidemiology of hidradenitis suppurativa and inflammatory bowel disease: are these two disease associated?.
        Actas Dermosifiliogr. 2016; 107: 8-12
        • Robert E.
        • Bodin F.
        • Paul
        • et al.
        Non-surgical treatments for hidradenitis suppurative: A systematic review.
        Ann Chir Plast Esth. 2017; 62: 274-294
        • Revuz J.
        Les traitements antibiotiques dans l'hidradénite suppurée-maladie de Verneuil.
        Ann Dermatol Venereol. 2012; 139: 532-541
        • Camisa C.
        • Sexton C.
        • Friedman C.
        Treatment of hidradenitis suppurativa with combination hypothalamic-pituitary-ovarian and adrenal suppression. A case report.
        J Reprod Med. 1989; 34: 543-546
        • Blok J.L.
        • van Hattem S.
        • Jonkman M.F.
        • Horvath B.
        Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review.
        Br J Dermatol. 2013; 168: 243-252
        • Van Rappard D.C.
        • Mekkes J.R.
        Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions.
        Br J Dermatol. 2012; 167: 206-208
        • van der Zee H.H.
        • Laman J.D.
        • de Ruiter L.
        • et al.
        Adalimumab (antitumour necrosis factor-ɑ) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
        Br J Dermatol. 2012; 166: 298-305
        • Paradela S.
        • Rodrıguez-Lojo R.
        • Fernandez-Torres R.
        • Arévalo P.
        • Fonseca E.
        Long-term efficacy of infliximab in hidradenitis suppurativa.
        J Dermatolog Treat. 2012; 23: 278-283
        • Ben Dhaou B.
        • Boussema F.
        • Zohra A.
        • Lilia B.
        • Rokbani L.
        Hidradenitis suppurativa (Verneuil’s disease).
        J Saudi Soc Dermatology Dermatol Surg. 2013; 17: 1-5
        • Smith M.K.
        • Nicholson C.L.
        • Parks-Miller A.
        • Hamzavi I.H.
        Hidradenitis suppurativa: an update on connecting the tracts.
        F1000Res. 2017; 6: 1272
        • Brown S.C.
        • Kazzazi N.
        • Lord P.H.
        Surgical treatment of perineal hidradenitis suppurativa with special reference to recognition of the perianal form.
        Br J Surg. 1986; 73: 978-980
        • Kagan R.J.
        • Yakuboff K.P.
        • Warner P.
        • Warden G.D.
        Surgical treatment of hidradenitis suppurativa: a 10-year experience.
        Surgery. 2005; 138: 734-740
        • Krause I.
        • Monselise Y.
        • Milo G.
        • Weinberger A.
        Anti-Saccharomyces cerevisiae antibodies: a novel serologic marker for Behçet’s disease.
        Clin Exp Rheumatol. 2002; 20: S21-S24
        • Riente L.
        • Chimenti D.
        • Pratesi F.
        • et al.
        Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis.
        J Rheumatol. 2004; 31: 920-924
        • Mallant-Hent R.
        • Mary B.
        • von Blomberg E.
        • et al.
        Disappearance of anti-Saccharomyces cerevisiae antibodies in celiac disease during a gluten-free diet.
        Eur J Gastroenterol Hepatol. 2006; 18: 75-78
        • Sakly W.
        • Jeddi M.
        • Ghedira I.
        Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis.
        Dig Dis Sci. 2008; 53: 1983-1987
        • Muratori P.
        • Muratori L.
        • Guidi M.
        • et al.
        Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases.
        Clin Exp Immunol. 2003; 132: 473-476
        • Fagoonee S.
        • De Luca L.
        • De Angelis C.
        • Castelli A.
        • Rizzetto M.
        • Pellicano R.
        Anti-Saccharomyces cerevisiae as unusual antibodies in autoimmune hepatitis.
        Minerva Gastroenterol Dietol. 2009; 55: 37-40
        • Sakly W.
        • Mankaï A.
        • Sakly N.
        • et al.
        Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes.
        Endocr Pathol. 2010; 21: 108-114
        • Yazici D.
        • Aydin S.Z.
        • Yavuz D.
        • et al.
        Anti-Saccharomyces cerevisiae antibodies (ASCA) are elevated in autoimmune thyroid disease.
        Endocrine. 2010; 38: 194-198
        • Cannistra C.
        • Finocchi V.
        • Trivisonno A.
        • Tambasco D.
        New perspectives in the treatment of hidradenitis suppurativa: Surgery and brewer’s yeast-exclusion diet.
        Surgery. 2013; 154: 1126-1130
        • Kaur M.R.
        • Lewis H.M.
        Hidradenitis suppurative treated with dapsone: a case series of five patients.
        J DermatTreat. 2006; 17: 211-213
        • Wollina H.
        • Koch A.
        • Heinig B.
        • Kittner T.
        • Nowak A.
        Acne inversa (hidradenite suppurative): A review with a focus on pathogenesis and treatment.
        Indian Dermatol Online J. 2013; 4: 2-11
        • Berni Canani R.
        • Paparo L.
        • Nocerino R.
        • et al.
        Gut microbiome as target for innovative strategies against food allergy.
        Front Immunol. 2019; 10: 191
        • Aitoro R.
        • Paparo L.
        • Amoroso A.
        • et al.
        Gut microbiota as a target for preventive and therapeutic intervention against food allergy.
        Nutrients. 2017; (9672)
        • Zhang Z.
        • Li C.
        • Zhao X.
        • et al.
        Anti-Saccharomyces cerevisiae anti- bodies associate with phenotypes and higher risk for surgery in Crohn’s disease: a meta-analysis.
        Dig Dis Sci. 2012; 57: 2944-2954
        • Coukos J.A.
        • Howard L.A.
        • Weinberg J.M.
        • Becker J.M.
        • Stucchi A.F.
        • Farraye F.A.
        ASCA IgG and CBir antibodies are associated with the development of Crohn’s disease and fistulae following ileal pouch-anal anastomosis.
        Dig Dis Sci. 2012; 57: 1544-1553
        • Dassopoulos T.
        • Nguyen G.C.
        • Talor M.V.
        • et al.
        NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn’s disease in African Americans.
        Am J Gastroenterol. 2010; 105: 378-386
        • Russell R.K.
        • Ip B.
        • Aldhous M.C.
        • et al.
        Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease.
        J Pediatr Gastroenterol Nutr. 2009; 48: 161-167
        • Odes S.
        • Friger M.
        • Vardi H.
        • et al.
        Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn’s disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel Disease.
        Inflamm Bowel Dis. 2007; 13: 874-881
        • Hunger R.E.
        • Surovy A.M.
        • Hassan A.S.
        • Braathen L.R.
        • Yawalkar N.
        Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor.
        Br J Dermatol. 2008; 158: 691-697
        • Untersmayr E.
        The influence of gastric digestion on the development of food allergy.
        Rev Fr Allergol. 2009; 55: 444-447
        • Ruiz Sánchez J.G.
        • Palma Milla S.
        • Pelegrina Cortés B.
        • López Plaza B.
        • Bermejo López L.M.
        • Gómez-Candela C.
        Una visión global de las reacciones adversas a alimentos: alergia e intolerancia alimentaria.
        Nutr Hosp. 2018; 35: 102-108
        • Barrea L.
        • Fabbrocini G.
        • Annunziata G.
        • et al.
        Role of nutrition and adherence to the Mediterranean diet in the multidisciplinary approach of hidradenitis suppurativa: Evaluation of nutritional status and its association with severity of disease.
        Nutrients. 2018; 11: 57
        • Silfvast-Kaiser A.
        • Youssef R.
        • Paek S.Y.
        Diet in hidradenitis: a review of published and lay literature.
        Int J Dermatol. 2019; 58: 1225-1230
        • Colboc H.
        • Fite C.
        • Cannistra C.
        • et al.
        Interest of brewer's yeast-exclusion diet in the management of hidradenitis suppurativa.
        J Clin Exp Dermatol Res. 2016; 7: 371-378
        • Chi L.
        • Mahbub R.
        • Gao B.
        • et al.
        Nicotine alters the gut microbiome and metabolites of gut-brain interactions in a sex-specific manner.
        Chem Res Toxicol. 2017; 30: 2110-2119
        • Thomas G.A.
        • Pullan R.D.
        • Zijlstra F.J.
        • et al.
        Effect of nicotine on large bowel mucus thickness, eicosanoids and faecal proteinase in ferrets.
        Eur J Gastroenterol Hepatol. 1997; 9: 179-182
        • Zijlstra F.J.
        • Srivastava E.D.
        • Rhodes M.
        • et al.
        Effect of nicotine on rectal mucus and mucosal eicosanoids.
        Gut. 1994; 35: 247-251